4//SEC Filing
Lehr Martin A. 4
Accession 0001842952-25-000019
CIK 0001842952other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:06 PM ET
Size
5.7 KB
Accession
0001842952-25-000019
Insider Transaction Report
Form 4
Lehr Martin A.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2025-02-13+802,700→ 802,700 totalExercise: $0.81Exp: 2035-02-12→ Common Stock (802,700 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2026, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.
Documents
Issuer
Context Therapeutics Inc.
CIK 0001842952
Entity typeother
Related Parties
1- filerCIK 0001861989
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:06 PM ET
- Size
- 5.7 KB